Walgreens Boots Is Returning To Health

January 12th 2025 –  The price of the Nasdaq listed US drugstore Walgreens Boots Alliance Inc exhibits a positive short-term trend reports Trend Intelligence, as its current price of around $11.76 sits some 45% higher than its November 2024 lows of just above $8.

Trend’s Analysis (click chart to expand): In our Walgreens Boots Alliance chart, Trend Intelligence uses its R* Momentum Indicator to report a positive trending R* area and yellow Signal Line. This is, and has shown over time to be, a positive trend signal.

In addition to our R* indicator, Walgreens Boots Alliance Inc price currently trades above Trend’s medium-term (yellow) moving average and above our Japanese Cloud indicator, shaded in blue. 

The combination of all signals corroborates Trend’s positive short-term trend rating on Walgreens Boots Alliance, as we project continued upward moves in its stock price until the trend shows signs of reversing.

Upside News: Walgreens stock spiked 27% last week as the firm reported fiscal first-quarter earnings and revenue that topped expectations, and maintained its fiscal 2025 adjusted earnings guidance of $1.40 to $1.80 per share. “Importantly, we started to progress on the opportunities that we consider essential to our longer term turnaround,” said CEO Tim Wentworth, according to CNBC News.

Downside News: Walgreens’ stock has fallen some 80% over the past five years, ranking the company among one of the worst-performing stocks. It has also agreed to close 1,200 stores, roughly 15% of its locations. Walgreens is much smaller than its rival CVS, suffering less room to negotiate prices with insurers and other healthcare vendors, reported Yahoo Finance back in December 2024.

Authored by Trend Intelligence, London

Recently published
Berkshire Hathaway: $6.1Bn of Stock Sold

Berkshire Hathaway: $6.1Bn of Stock Sold

November 3rd 2025 – Berkshire Hathaway's US listed equity price has entered into a short-term negative trend reports Trend Intelligence. The signal comes after the investment giant disclosed over the weekend that it had sold another $6.1 billion of common stock in the...

AstraZeneca’s Trump Card

AstraZeneca’s Trump Card

October 12th 2025 – AstraZeneca's London listed equity price continues in a strongly positive short-term trend after the pharmaceutical giant agreed to a new range of measures giving US patients access to medicine at heavily discounted prices. As part of the historic...

‘Big Short’ Michael Burry Likes Estée Lauder

‘Big Short’ Michael Burry Likes Estée Lauder

September 8th 2025 – Big Short hedge fund manager Michael Burry and his Scion Asset Management have been building increasingly large positions in the US cosmetics firm Estée Lauder. In addition its existing $12 million of equity held,  Scion recently purchased 500,000...

Trend Masters: Jim Simons & Renaissance

Trend Masters: Jim Simons & Renaissance

James Harris 'Jim' Simons (April 1938 – May 2024) was a renowned American hedge fund manager, investor and mathematician.  In the 1980’s Jim created Renaissance Technologies, one of the first quantitative hedge funds. Simons soon came to be a known as a pioneer in the...

Berkshire Hathaway: $6.1Bn of Stock Sold

Berkshire Hathaway: $6.1Bn of Stock Sold

November 3rd 2025 – Berkshire Hathaway's US listed equity price has entered into a short-term negative trend reports Trend Intelligence. The signal comes after the investment giant disclosed over the weekend that it had sold another $6.1 billion of common stock in the...

AstraZeneca’s Trump Card

AstraZeneca’s Trump Card

October 12th 2025 – AstraZeneca's London listed equity price continues in a strongly positive short-term trend after the pharmaceutical giant agreed to a new range of measures giving US patients access to medicine at heavily discounted prices. As part of the historic...

‘Big Short’ Michael Burry Likes Estée Lauder

‘Big Short’ Michael Burry Likes Estée Lauder

September 8th 2025 – Big Short hedge fund manager Michael Burry and his Scion Asset Management have been building increasingly large positions in the US cosmetics firm Estée Lauder. In addition its existing $12 million of equity held,  Scion recently purchased 500,000...

Trend Masters: Jim Simons & Renaissance

Trend Masters: Jim Simons & Renaissance

James Harris 'Jim' Simons (April 1938 – May 2024) was a renowned American hedge fund manager, investor and mathematician.  In the 1980’s Jim created Renaissance Technologies, one of the first quantitative hedge funds. Simons soon came to be a known as a pioneer in the...